CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-23 | Myers Scott Dunseth Director | Grant or award | +39,409 | $1.46 | $58K | 80,845 |
| 2019-12-23 | Myers Scott Dunseth Director | Grant or award · Warrants | +19,704 | $0.13 | $2K | 19,704 |
| 2019-12-12 | SPRINGER TIMOTHY A Director | Other acquisition | +1,237,028 | 7,293,625 | ||
| 2019-12-02 | Brunn Carsten President and CEO | Sale | −14,272 | $1.53 | $22K | 70,914 |
| 2019-12-01 | Brunn Carsten President and CEO | Exercise or conversion | +43,750 | 85,186 | ||
| 2019-12-01 | Brunn Carsten President and CEO | Exercise or conversion · Restricted Stock Units | −43,750 | 131,250 | ||
| 2019-11-20 | COX CARRIE SMITH Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-10-07 | Smolinski Stephen Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2019-10-07 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2019-10-07 | Johnston Lloyd P. COO and SVP, R&D | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2019-10-07 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2019-09-03 | SPRINGER TIMOTHY A Director | Other disposition | −1,237,028 | 0 | ||
| 2019-09-03 | Dahms Bradford D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2019-08-20 | SPRINGER TIMOTHY A Director | Grant or award | +1,600,000 | $1.81 | $2.9M | 6,056,597 |
| 2019-08-20 | SPRINGER TIMOTHY A Director | Grant or award | +1,100,000 | $1.81 | $2.0M | 1,545,576 |
| 2019-08-20 | Smolinski Stephen Chief Commercial Officer | Grant or award | +13,812 | $1.81 | $25K | 13,812 |
| 2019-08-20 | Myers Scott Dunseth Director | Grant or award | +41,436 | $1.81 | $75K | 41,436 |
| 2019-08-20 | Kogan Elona Esq. General Counsel | Grant or award | +82,872 | $1.81 | $150K | 182,872 |
| 2019-08-20 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award | +50,000 | $1.81 | $91K | 86,114 |
| 2019-08-20 | Brunn Carsten President and CEO | Grant or award | +41,436 | $1.81 | $75K | 41,436 |
Page 29 of 32 · 631 trades